Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial.
Sara MijwelMalin BackmanKate A BolamAnna JervaeusCarl Johan SundbergSara MargolinMaria BrowallHelene RundqvistYvonne WengströmPublished in: Breast cancer research and treatment (2017)
Clinicaltrials.gov Registration Number: NCT02522260.